GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.

She lost 250 pounds and thought her journey was over... but then she discovered something most people don't talk about.

OnlineSemaglutide.org exists to make evidence‑based GLP‑1 medications simple, safe, and affordable for adults who deserve ...

A new study reveals that bariatric surgery results in significantly greater weight loss compared to popular GLP-1 drugs.

Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist ...

Patients with type 2 diabetes had a lower risk of glaucoma when they used glucagon-like peptide 1 (GLP-1) receptor agonists across multiple studies.

Mark Cuban's company is partnering with a Californian health care business with the goal of providing more affordable GLP-1 ...

The companies are working together to make it easier for companies to offer health plans that include these medications.

Back in May 2025, dapiglutide failed to impress in a phase 2 trial, mustering up to an average 4.3% reduction in weight loss when given at the 6 mg dose. The 54-person study involved administering ...